Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    07-January-2001      
Issue 7 Next Update - 14:00 UTC 08:00 EST    08-January-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya




















Proceed To Article In Today's Vidyya
pregnant profile
Pregnant women may be at increased risk of fatal lactic acidosis when prescribed a particular combination of HIV drugs. Get the complete information in today's issue.


Proceed To Article FDA/Bristol Myers Squibb Issues Caution For HIV Combination Therapy With Zerit And Videx In Pregnant Women
The FDA and Bristol Myers Squibb are warning health care professionals that pregnant women may be at increased risk of fatal lactic acidosis when prescribed the combination of the HIV drugs stavudine (Zerit) and didanosine (Videx or Videx EC) with other antiretroviral agents. More...

Proceed To Article Prescribing Information: Videx
Videx (didanosine) in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection. Videx (didanosine) does not cure HIV infection or prevent passing HIV to others. Fatal and nonfatal pancreatitis has occurred when Videx was used alone or as part of a combination regimen. Patients treated with Videx in a combination regimen that includes stavudine with or without hydroxyurea may be at increased risk for pancreatitis. Get the full prescribing information for Videx in today's issue. More...

Proceed To Article Prescribing Information: Ziret Zerit (stavudine), in combination with other antiretroviral agents, is indicated for the treatment of HIV-1 infection. Zerit (stavudine) does not cure HIV infection or prevent passing HIV to others. There have been cases of lactic acid buildup in the blood and enlarged liver, including fatal cases. Fatal and nonfatal pancreatitis has occurred when Zerit was part of a combination regimen that included didanosine, with or without hydroxyurea. Zerit may cause numbness, tingling or pain in the hands or feet (neuropathy). This risk is increased in patients with HIV disease or a history of neuropathy. If this occurs, lowering the dose or stopping Zerit to improve symptoms. Patients treated with Zerit in combination with other medicines that may cause similar side effects may have a higher chance of developing these side effects. The most frequent side effects associated with Zerit are nausea, diarrhea, headache, rash, and neuropathy. Vidyya has the full prescribing information for Zerit available for you in today's issue. More...

Proceed To Article UK NHS Invests In Equipment To Cut Risk Of CJD Transmission
A massive injection of £200 million is set to ensure that NHS decontamination and sterilization services are modernized so that all surgical equipment in hospitals is cleaned and sterilised to the highest possible standard to protect patients from a theoretical risk of variant Creutzfeldt Jakob Disease (vCJD). More...

Proceed To Article

Latest Creutzfeldt Jakob Disease (CJD & vCJD) Statistics
OOn 03 January 2001, the UK Department of Health issued the latest information about the numbers of known cases of Creutzfeldt Jakob disease. The position on variant Creutzfeldt Jakob disease (vCJD) - the form of the disease thought to be linked to Bovine Spongiform Encephalitis--appears in today's issue in table format. In the year 2000 there were 72 total cases, down from the previous three years. As the world begins to worry about vCJD, Vidyya will keep an eye on the statistics coming from the UK and report on the newly diagnosed cases in France. More...


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.